Linyi People's Hospital   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Linyi China (1891)

Organization Overview

First Clinical Trial
2014
NCT02412319
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Linyi People 's Hospital | Linyi People's Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Anemia, Aplastic (Phase 4)

Fibrosis (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hypertension, Portal (Phase 4)

Irritable Bowel Syndrome (Phase 4)

Ischemia (Phase 2)

Leukemia (Phase 3)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Liver Cirrhosis (Phase 4)

Purpura, Thrombocytopenic, Idiopathic (Phase 3)

Stroke (Phase 2)

Syndrome (Phase 4)

Thrombocytopenia (Phase 3)

Tooth, Impacted (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 18
  • # of Trial APIs: 29